← Back to Search

Financial Navigation for Blood Cancer Survivors

N/A
Waitlist Available
Led By Susan K Parsons, MD, MRP
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial studies how young adult cancer survivors (18-39y) experience financial strain and seeks to find ways to help.

Who is the study for?
This trial is for young adults aged 18-39 in the U.S. who were diagnosed with blood cancer (like leukemia or lymphoma) during childhood or early adulthood, are off treatment or on a stable regimen, and have been living with their diagnosis for at least three years. They must read English and not be dependent on a parent's insurance.Check my eligibility
What is being tested?
The study tests financial navigation services to address money-related stress in young adult blood cancer survivors. Participants will receive different levels of support: active guidance, occasional help, or no special assistance from the study to manage financial challenges.See study design
What are the potential side effects?
Since this trial focuses on financial counseling rather than medical intervention, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Personal Financial Wellness Scale (PFW)
Secondary outcome measures
Health-Related Quality of Life (HrQoL) Measures

Trial Design

3Treatment groups
Active Control
Group I: Active NavigationActive Control1 Intervention
Active navigation with the study-based financial navigator scheduling four check-in meetings throughout the study with the participant. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Group II: Ad Hoc NavigationActive Control1 Intervention
Ad hoc navigation in which participant is provided study-based financial navigator to contact as needed. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.
Group III: No study-based NavigationActive Control1 Intervention
No access to a study-based financial navigator, but access to a national hotline through the Leukemia & Lymphoma Society. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Find a Location

Who is running the clinical trial?

Tufts Medical CenterLead Sponsor
253 Previous Clinical Trials
253,138 Total Patients Enrolled
The Leukemia and Lymphoma SocietyOTHER
82 Previous Clinical Trials
16,871 Total Patients Enrolled
Susan K Parsons, MD, MRPPrincipal InvestigatorTufts Medical Center

Media Library

Active Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05620979 — N/A
Financial Stress Research Study Groups: Active Navigation, Ad Hoc Navigation, No study-based Navigation
Financial Stress Clinical Trial 2023: Active Navigation Highlights & Side Effects. Trial Name: NCT05620979 — N/A
Active Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05620979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for enrolment in this clinical trial currently?

"Not currently, as per information available on clinicaltrials.gov. This particular trial was initially advertised on February 14th 2022 and last updated November 11th 2022; however, there are 524 other trials now recruiting participants."

Answered by AI

Are there any eligibility criteria that would preclude me from participating in this trial?

"This trial is accepting applications from individuals aged 18-39 with a history of haematological malignancies. The prerequisites for enrolment include: A past diagnosis and treatment involving leukaemia, lymphoma, myeloma, myelodysplastic syndrome or myeloproliferative neoplasm; 3 years post blood cancer diagnosis without any prior secondary tumours; residing in the United States and possessing sufficient English literacy skills; being off chemotherapy/on stable long term oral anti-cancer medication if applicable."

Answered by AI

How many venues are hosting this research endeavor?

"This medical trial is currently recruiting patients from five different locations, including Bon Secours Mercy Health System in Greenville, Children's Hospital Los Angeles in Los Angeles, and MD Anderson in Houston. An additional 5 sites are also involved."

Answered by AI

Is this research open to adult participants?

"According to the study's entry criteria, only individuals between 18 and 39 years of age can participate. Those under 18 and over 65 have other options however, with 66 trials available for minors and 464 studies aimed at senior citizens."

Answered by AI
~82 spots leftby Apr 2025